These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10803803)

  • 1. Double-blind, crossover, placebo-controlled clinical trial with L-acetylcarnitine in patients with degenerative cerebellar ataxia.
    Sorbi S; Forleo P; Fani C; Piacentini S
    Clin Neuropharmacol; 2000; 23(2):114-8. PubMed ID: 10803803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind crossover study with physostigmine in patients with degenerative cerebellar diseases.
    Wessel K; Langenberger K; Nitschke MF; Kömpf D
    Arch Neurol; 1997 Apr; 54(4):397-400. PubMed ID: 9109740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind crossover study with levorotatory form of hydroxytryptophan in patients with degenerative cerebellar diseases.
    Wessel K; Hermsdörfer J; Deger K; Herzog T; Huss GP; Kömpf D; Mai N; Schimrigk K; Wittkämper A; Ziegler W
    Arch Neurol; 1995 May; 52(5):451-5. PubMed ID: 7733838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
    Feil K; Adrion C; Teufel J; Bösch S; Claassen J; Giordano I; Hengel H; Jacobi H; Klockgether T; Klopstock T; Nachbauer W; Schöls L; Stendel C; Uslar E; van de Warrenburg B; Berger I; Naumann I; Bayer O; Müller HH; Mansmann U; Strupp M
    BMC Neurol; 2017 Jan; 17(1):7. PubMed ID: 28068987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetyl-l-carnitine versus placebo for migraine prophylaxis: A randomized, triple-blind, crossover study.
    Hagen K; Brenner E; Linde M; Gravdahl GB; Tronvik EA; Engstrøm M; Sonnewald U; Helde G; Stovner LJ; Sand T
    Cephalalgia; 2015 Oct; 35(11):987-95. PubMed ID: 25601916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled study of L-acetylcarnitine for the treatment of hyperactive behavior in fragile X syndrome.
    Torrioli MG; Vernacotola S; Mariotti P; Bianchi E; Calvani M; De Gaetano A; Chiurazzi P; Neri G
    Am J Med Genet; 1999 Dec; 87(4):366-8. PubMed ID: 10588848
    [No Abstract]   [Full Text] [Related]  

  • 7. L-Acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine.
    Bersani G; Meco G; Denaro A; Liberati D; Colletti C; Nicolai R; Bersani FS; Koverech A
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1219-25. PubMed ID: 23428336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
    Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
    J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects.
    Martinotti G; Andreoli S; Reina D; Di Nicola M; Ortolani I; Tedeschi D; Fanella F; Pozzi G; Iannoni E; D'Iddio S; Prof LJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):953-8. PubMed ID: 21256179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Acetyl-DL-Leucine in Certain Types of Cerebellar Ataxia: The ALCAT Randomized Clinical Crossover Trial.
    Feil K; Adrion C; Boesch S; Doss S; Giordano I; Hengel H; Jacobi H; Klockgether T; Klopstock T; Nachbauer W; Schöls L; Steiner KM; Stendel C; Timmann D; Naumann I; Mansmann U; Strupp M;
    JAMA Netw Open; 2021 Dec; 4(12):e2135841. PubMed ID: 34905009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain.
    Onofrj M; Fulgente T; Melchionda D; Marchionni A; Tomasello F; Salpietro FM; Alafaci C; De Sanctis E; Pennisi G; Bella R
    Int J Clin Pharmacol Res; 1995; 15(1):9-15. PubMed ID: 7490173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of L-acetylcarnitine on cirrhotic patients with hepatic coma: randomized double-blind, placebo-controlled trial.
    Malaguarnera M; Pistone G; Astuto M; Vecchio I; Raffaele R; Lo Giudice E; Rampello L
    Dig Dis Sci; 2006 Dec; 51(12):2242-7. PubMed ID: 17080254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS.
    Beghi E; Pupillo E; Bonito V; Buzzi P; Caponnetto C; Chiò A; Corbo M; Giannini F; Inghilleri M; Bella VL; Logroscino G; Lorusso L; Lunetta C; Mazzini L; Messina P; Mora G; Perini M; Quadrelli ML; Silani V; Simone IL; Tremolizzo L;
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):397-405. PubMed ID: 23421600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acetyl-L-carnitine in the treatment of painful peripheral neuropathies in HIV+ patients.
    Scarpini E; Sacilotto G; Baron P; Cusini M; Scarlato G
    J Peripher Nerv Syst; 1997; 2(3):250-2. PubMed ID: 10975731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
    Ristori G; Romano S; Visconti A; Cannoni S; Spadaro M; Frontali M; Pontieri FE; Vanacore N; Salvetti M
    Neurology; 2010 Mar; 74(10):839-45. PubMed ID: 20211908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
    Malaguarnera M; Bella R; Vacante M; Giordano M; Malaguarnera G; Gargante MP; Motta M; Mistretta A; Rampello L; Pennisi G
    Scand J Gastroenterol; 2011 Jun; 46(6):750-9. PubMed ID: 21443422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the chronic treatment with L-acetylcarnitine in Down's syndrome].
    De Falco FA; D'Angelo E; Grimaldi G; Scafuro F; Sachez F; Caruso G
    Clin Ter; 1994 Feb; 144(2):123-7. PubMed ID: 8181206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia.
    Balercia G; Regoli F; Armeni T; Koverech A; Mantero F; Boscaro M
    Fertil Steril; 2005 Sep; 84(3):662-71. PubMed ID: 16169400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain.
    Bonavita E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):511-6. PubMed ID: 3781687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U
    Int J Clin Pharmacol Res; 1990; 10(1-2):75-9. PubMed ID: 2201659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.